The diagnostics company Gradientech today announces that data from the successfully completed US pre-clinical evaluation of QuickMIC® will be presented at the ASM Microbe conference in Atlanta, Georgia, June 13th-17th.
The diagnostics company Gradientech today announces that data from the successfully completed US pre-clinical evaluation of QuickMIC® will be presented at the ASM Microbe conference in Atlanta, Georgia, June 13th-17th.
The diagnostics company Gradientech today announces that Biomedica Medizinprodukte GmbH, its appointed distributor for Austria, Switzerland, and Central Eastern Europe, has acquired its first customer for QuickMIC® in clinical routine use.
Diagnostikbolaget Gradientech meddelar idag att Biomedica Medizinprodukte GmbH, bolagets distributör för Österrike, Schweiz och centrala Östeuropa, har installerat QuickMIC® hos sin första sjukhuskund för klinisk rutinanvändning.
Gradientech AB (publ) interim report for Q1 2024 is now available on the company’s website www.gradientech.se.
Gradientech AB (publ) delårsrapport för Q1 2024 är nu tillgänglig på bolagets hemsida www.gradientech.se.
Diagnostikföretaget Gradientech har fått besked om att de beviljas patenträttigheter i Kina för sin QuickMIC®-kassett, testenheten för engångsbruk som är del i bolagets diagnostiksystem QuickMIC® för ultrasnabb antibiotikaresistensbestämning (AST).
The diagnostics company Gradientech reports having received a Notification to Grant Patent Rights in China for its QuickMIC® cassette, the single-use test device in the QuickMIC® diagnostic system for ultra-rapid antibiotic susceptibility testing (AST).
The diagnostics company Gradientech today announces the release of its new ebook “Stop treating all patients equally” – a future approach for individualised and improved sepsis patient management.
Diagnostikföretaget Gradientech lanserar sin nya e-bok med titeln “Stop treating all patients equally” – en framtida strategi för individanpassad och förbättrad behandling av sepsispatienter.
The diagnostics company Gradientech announces the presentation of new performance data from clinical, real-world evaluations with its QuickMIC[®] system for ultra-rapid antibiotic susceptibility testing (AST) at ESCMID Global 2024 in Barcelona, Spain, April 27th-30th.